Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Anders Hove reported a 6.70% stake in Karyopharm Therapeutics Inc. (Schedule 13G)
Event May 13, 2026 · Filed May 15, 2026
Anders Hove reported a 6.70% stake in Karyopharm Therapeutics Inc., 1,518,113 shares, as a passive investor on May 13, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 1,518,113
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.80% | 637,608 |
| ACORN CAPITAL ADVISORS GP, LLC | 2.80% | 637,608 |
| ACORN BIOVENTURES 2, L.P. | 3.90% | 880,505 |
| Acorn Capital Advisors GP 2, LLC | 3.90% | 880,505 |
| Anders Hove | 6.70% | 1,518,113 |
Source
Related
- Karyopharm Therapeutics Inc.
- Anders Hove
- Karyopharm Therapeutics Inc. shareholders
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G · Millennium Management LLC · Sep 4, 2026
- Form 4 · Abate Kristin · Sep 2, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026